Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats

Mineralys Therapeutics appointed biopharma commercial veterans Kristine Peterson and Lonnel Coats to its board of directors. Peterson previously led commercial operations at Valeritas, Johnson & Johnson, Biovail and Bristol-Myers Squibb; Coats was CEO of Lexicon Pharmaceuticals and held leadership roles at Eisai.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.